ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,554,052 | -70.7% | 686,533 | -42.9% | 0.04% | -56.8% |
| Q4 2022 | $18,928,366 | -7.8% | 1,201,801 | -7.9% | 0.09% | -27.3% |
| Q3 2022 | $20,535,000 | +2.1% | 1,304,624 | -9.4% | 0.12% | -61.0% |
| Q2 2022 | $20,103,000 | -19.0% | 1,440,075 | 0.0% | 0.31% | +2.0% |
| Q1 2022 | $24,827,000 | +53.1% | 1,440,075 | +29.1% | 0.30% | +85.4% |
| Q4 2021 | $16,213,000 | +82.9% | 1,115,075 | +126.4% | 0.16% | +343.2% |
| Q3 2021 | $8,865,000 | -5.4% | 492,500 | -7.7% | 0.04% | -28.8% |
| Q2 2021 | $9,371,000 | +837.1% | 533,662 | +1244.2% | 0.05% | +940.0% |
| Q1 2021 | $1,000,000 | – | 39,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |